Entasis Therapeutics Holdings Inc. (29) | Business Finance (17)

Browse by Subcategory

Recent Contracts

Form of Registration Rights Agreement (Filed With SEC on May 3, 2021)
Securities Purchase Agreement, dated May 3, 2021, by and between the Company and Innoviva (Filed With SEC on May 3, 2021)
Form of Warrant Certificate (Filed With SEC on May 3, 2021)
Form of Restricted Stock Unit Grant Agreement (Filed With SEC on November 6, 2020)
Investor Rights Agreement, dated April 22, 2020, by and between the Company and Innoviva (Filed With SEC on April 22, 2020)
Form of Restricted Stock Unit Grant Notice (Time-Based) (Filed With SEC on November 6, 2020)
Form of Pre-Funded Common Stock Purchase Warrant (Filed With SEC on September 1, 2020)
Registration Rights Agreement, dated September 1, 2020, by and between the Company and the Investors named therein (Filed With SEC on September 1, 2020)
Securities Purchase Agreement, dated August 27, 2020, by and between the Company and the Investors named therein (Filed With SEC on September 1, 2020)
Form of Common Stock Purchase Warrant (Filed With SEC on September 1, 2020)
Registration Rights Agreement, dated April 22, 2020, by and between the Company and Innoviva (Filed With SEC on April 22, 2020)
Form of Investor Rights Agreement (Filed With SEC on April 13, 2020)
Securities Purchase Agreement, dated April 12, 2020, by and between the Company and Innoviva (Filed With SEC on April 13, 2020)
Form of Registration Rights Agreement (Filed With SEC on April 13, 2020)
Form of Warrant Certificate (Filed With SEC on April 13, 2020)
Common Stock Purchase Agreement, dated as of October 21, 2019, by and between Entasis Therapeutics Holdings Inc and Aspire Capital Fund, LLC (Filed With SEC on October 21, 2019)
Registration Rights Agreement, dated as of October 21, 2019, by and between Entasis Therapeutics Holdings Inc. and Aspire Capital Fund, LLC (Filed With SEC on October 21, 2019)